Novel Approaches in the Treatment of Antipsychotic-Induced Hyperprolactinemia:The Role of Partial Agonists of D2 Dopaminergic Receptors

Publisher： Bentham Science Publishers

E-ISSN： 2212-3334|4|3|230-240

ISSN： 1872-2148

Source： Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol.4, Iss.3, 2010-11, pp. : 230-240

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Antipsychotic-Induced Hyperprolactinemia: An Update on the Role of the Dopaminergic Receptors D2 Partial Agonist Aripiprazole

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 8, Iss. 1, 2014-01 ,pp. : 30-37

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Beta2 Agonists in Respiratory Medicine with Particular Attention to Novel Patents and Effects on Endocrine System and Immune Response

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 230-236

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 163-175

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Anaplastic Thyroid Cancer: Is there a Role for PPAR&ggr; Agonists?

By  

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Vol. 2, Iss. 3, 2008-11 ,pp. : 194-199

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Strategies for the Treatment of Allergy

By  

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 2, 2007-01 ,pp. : 95-99

Bentham Science Publishers

Access to resources Recommend Favorite